Wockhardt Exits US Generics, Focuses on Antibiotics and Insulin
Summary
Wockhardt exits loss-making US generics business, shifts focus to drug discovery and insulin portfolios, aiming to improve profits and target emerging markets.

Wockhardt exits loss-making US generics business, shifts focus to drug discovery and insulin portfolios, aiming to improve profits and target emerging markets.
Swaraj Tractors, part of Mahindra Group, achieves a significant milestone by rolling out its 25th lakh tractor in Mohali, Punjab.
Reliance Industries unveils Reliance Intelligence with Google and Meta partnerships, aiming to revolutionize AI sector in India.
Samvardhana Motherson International approves acquisition of an 81% stake in Yutaka Giken Co. Ltd. for $184 million, expanding reach with Japanese OEMs and strengthening partnership with Honda.
Elon Musk's xAI files lawsuit against former engineer for stealing cutting-edge AI technologies for rival OpenAI, intensifying tech competition.
Reliance Retail's RCPL to consolidate all consumer brands under RIL, targeting rapid growth in the booming Indian consumer market with a clear focus and global expansion plans.
Intel amended the CHIPS Act funding deal with the U.S. Department of Commerce to receive $5.7 billion in cash sooner, giving them more flexibility. The deal includes retaining some guardrails to prevent certain fund uses.